Socio-demographic factors influence chronic proton pump inhibitor use by a large population in the Netherlands

Alimentary Pharmacology and Therapeutics

Volumn 29, Issue 5, 2009, Pages 571-579

  Van Boxel, O S ^a   Hagenaars, M P ^b   Smout, A J P M ^a   Siersema, P D ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Achmea Health Insurance ^*  (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; NONSTEROID ANTIINFLAMMATORY AGENT; PROKINETIC AGENT; PROTON PUMP INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AGED; ARTICLE; DEMOGRAPHY; DRUG USE; EDUCATION; FEMALE; HUMAN; INCOME; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PATIENT COMPLIANCE; PRESCRIPTION; PRIORITY JOURNAL; SOCIAL STATUS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COHORT STUDIES; DRUG PRESCRIPTIONS; DRUG UTILIZATION; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NETHERLANDS; PROTON PUMP INHIBITORS; RETROSPECTIVE STUDIES; SOCIOECONOMIC FACTORS; TIME FACTORS; YOUNG ADULT;

EID: 59149103153     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2008.03900.x     Document Type: Article

References (32)

1. Moayyedi P, Axon AT. Review article: gastro-oesophageal reflux disease - the extent of the problem. Aliment Pharmacol Ther 2005 22 (Suppl. 1 11 9.
2. Dean BB, Gano AD Jr., Knight K, et al. Effectiveness of proton pump inhibitors in nonerosive reflux disease. Clin Gastroenterol Hepatol 2004 2 : 656 64.
3. DeVault KR, Castell DO. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol 2005 100 : 190 200.
4. Peura DA. Prevention of nonsteroidal anti-inflammatory drug-associated gastrointestinal symptoms and ulcer complications. Am J Med 2004 117 (Suppl. 5A 63S 71S.
5. Talley NJ, Vakil N. Guidelines for the management of dyspepsia. Am J Gastroenterol 2005 100 : 2324 37.
6. Raghunath AS, O'Morain C, McLoughlin RC. Review article: the long-term use of proton-pump inhibitors. Aliment Pharmacol Ther 2005 22 (Suppl. 1 55 63.
7. Laheij RJ, Sturkenboom MC, Hassing RJ, et al. Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. JAMA 2004 292 : 1955 60.
8. Dial S, Delaney JA, Barkun AN, et al. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA 2005 294 : 2989 95.
9. Lemmens VE, van Halteren AH, Janssen-Heijnen ML, et al. Adjuvant treatment for elderly patients with stage III colon cancer in the southern Netherlands is affected by socioeconomic status, gender, and comorbidity. Ann Oncol 2005 16 : 767 72.
10. Bongers FJ, Schellevis FG, Bakx C, et al. Treatment of heart failure in Dutch general practice. BMC Fam Pract 2006 7 : 40.
11. Targownik LE, Metge C, Roos L, et al. The prevalence of and the clinical and demographic characteristics associated with high-intensity proton pump inhibitor use. Am J Gastroenterol 2007 102 : 942 50.
12. Knottnerus JA, ten VeldenGH. Dutch doctors and their patients - effects of health care reform in the Netherlands. N Engl J Med 2007 357 : 2424 6.
13. Enthoven AC, van d V. Going Dutch - managed-competition health insurance in the Netherlands. N Engl J Med 2007 357 : 2421 3.
14. World Health Organisation. Available at: http://www.whocc.no/atcddd/ (accessed March 2008).
15. Benner JS, Glynn RJ, Mogun H, et al. Long-term persistence in use of statin therapy in elderly patients. JAMA 2002 288 : 455 61.
16. Sikka R, Xia F, Aubert RE. Estimating medication persistency using administrative claims data. Am J Manag Care 2005 11 : 449 57.
17. Nederlands Huisartsen Genootschap. Available at: http://nhg.artsennet.nl/ upload/104/standaarden/M36/start.htm (accessed January 2008).
18. Van der Heyden JH, Demarest S, Tafforeau J, et al. Socio-economic differences in the utilisation of health services in Belgium. Health Policy 2003 65 : 153 65.
19. Liberatos P, Link BG, Kelsey JL. The measurement of social class in epidemiology. Epidemiol Rev 1988 10 : 87 121.
20. Centraal Bureau voor de Statistiek. Available at: http://www.cbs.nl/nl http://NL/menu/themas/dossiers/nederlandregionaal/cijfers/incidenteel/maatwerk/ kerncijfers-postcodegebieden-2004.htm (accessed March 2008).
21. Perkins AJ, Kroenke K, Unutzer J, et al. Common comorbidity scales were similar in their ability to predict health care costs and mortality. J Clin Epidemiol 2004 57 : 1040 8.
22. Nielsen MW, Hansen EH, Rasmussen NK. Prescription and non-prescription medicine use in Denmark: association with socio-economic position. Eur J Clin Pharmacol 2003 59 : 677 84.
23. Kulu-Glasgow I, Delnoij D, de BD. Self-referral in a gatekeeping system: patients' reasons for skipping the general-practitioner. Health Policy 1998 45 : 221 38.
24. Scott A, Shiell A, King M. Is general practitioner decision making associated with patient socio-economic status? Soc Sci Med 1996 42 : 35 46.
25. Sutton M. Vertical and horizontal aspects of socio-economic inequity in general practitioner contacts in Scotland. Health Econ 2002 11 : 537 49.
26. Eggen AE. Pattern of drug use in a general population - prevalence and predicting factors: the Tromso study. Int J Epidemiol 1994 23 : 1262 72.
27. Lin M, Gerson LB, Lascar R, et al. Features of gastroesophageal reflux disease in women. Am J Gastroenterol 2004 99 : 1442 7.
28. Koloski NA, Talley NJ, Boyce PM. Epidemiology and health care seeking in the functional GI disorders: a population-based study. Am J Gastroenterol 2002 97 : 2290 9.
29. Talley NJ, Lauritsen K. The potential role of acid suppression in functional dyspepsia: the BOND, OPERA, PILOT, and ENCORE studies. Gut 2002 50 (Suppl. 4 iv36 41.
30. Centraal Begeleidingsorgaan. Available at: http://www.cbo.nl/product/ richtlijnen/folder20021023121843/richtlijnnsaid.pdf/view (accessed April 2008).
31. Moayyedi P, Talley NJ. Gastro-oesophageal reflux disease. Lancet 2006 367 : 2086 100.
32. Jansson C, Nordenstedt H, Johansson S, et al. Relation between gastroesophageal reflux symptoms and socioeconomic factors: a population-based study (the HUNT Study). Clin Gastroenterol Hepatol 2007 5 : 1029 34.